Roche Sequencing USA Information
Summary
Roche Sequencing USA is a private company that has been in the industry for 20 years. The company currently specializes in the Biotechnology, Biotechnology areas. Its headquarters is located at Charlestown, Massachusetts, USA. The number of employees ranges from 100 to 250. The annual revenue of Roche Sequencing USA varies between 100K and 5.0M. To connect with Roche Sequencing USA employee register on SignalHire.
Organization Website | sequencing.roche.com |
Social Links |   |
Phone Number | 617-872-0414 |
Industries | |
Headquarters Location | 9115 Hague Rd, Indianapolis, Indiana, 46256 US |
Employees Size | 100-200 employees |
Specialties | Next-generation Sequencing, qPCR, PCR, Evolved enzymes |
SIC Code | 2836 |
DMA Code | Greater Boston |
Founded | 2006 |
Estimated Annual Revenue | $100K - 5.0M |
Operating Status | Subsidiary |
Competitors
Founded | Type | Employees | Revenue | Funding | |
|---|---|---|---|---|---|
| 1998 | Privately Held | 25 - 100 | 15.7M | $6.1M | |
| 2014 | Privately Held | 25 - 100 | 11.2M | $34.8M | |
| 1984 | Privately Held | 100 - 250 | 26M | $82M | |
| 2006 | Privately Held | 100 - 250 | 20M | $511.6M |
Employees Turnover 4 quarter 2025
Number of employees switched from or switched to
Length of Employment
Employee tenure at Roche Sequencing USA shows a diverse range of experience levels:
6% have been with the company for less than 1 year10% for 1–2 years12% for 3–4 years19% for 5–7 years17% for 8–10 years37% have over 11 years of service at Roche Sequencing USAEx-employees positions
Similar Companies
FAQ
Data Privacy
GDPR COMPLIANT
SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.
CCPA COMPLIANT
SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.
